| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bioxcel Therapeutics, Inc. (BTAI) has 11 insiders with recent SEC Form 4 filings, including 27 buys and 0 sells. BTAI is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - | |
| Dir | 17.0K | $20.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2019 | Yocca Frank88 | Chief Scientific Officer | Buy | 6,547 | $8.67 | $56,762.49 | +353.9% | |
| Dec 14, 2018 | Mehta Vimal92 | CEO, President, Secretary | Buy | 2,000 | $4.38 | $8,766.00 | +9.9% | |
| Dec 7, 2018 | Mueller Peter | Director | Buy | 8,795 | $5.01 | $44,045.05 | +1.5% | |
| Dec 4, 2018 | Mueller Peter | Director | Buy | 4,007 | $5.13 | $20,544.17 | +0.5% | |
| Dec 4, 2018 | Mehta Vimal92 | CEO, President, Secretary | Buy | 1,000 | $5.12 | $5,120.00 | +22.2% | |
| Dec 4, 2018 | Yocca Frank88 | Chief Scientific Officer | Buy | 900 | $5.21 | $4,692.24 | +38.3% | |
| Dec 3, 2018 | Mehta Vimal92 | CEO, President, Secretary | Buy | 1,000 | $5.17 | $5,165.00 | +15.6% | |
| Dec 3, 2018 | Steinhart Richard I87 | Chief Financial Officer | Buy | 500 | $5.20 | $2,599.95 | +50.0% | |
| Nov 30, 2018 | Steinhart Richard I87 | Chief Financial Officer | Buy | 500 | $5.00 | $2,500.00 | +100.0% | |
| Nov 30, 2018 | Yocca Frank88 | Chief Scientific Officer | Buy | 450 | $5.20 | $2,339.55 | +90.0% |